David Brazier

Senior Vice President – Clinical Operations

David brings over 30 years of experience in overseeing, managing, and monitoring Phase I-III clinical trial operations across North America, Latin America, Europe, and Australia. He began his early research career as a chemist, eventually transitioning into clinical research while at Genetics Institute, one of the largest and most successful early biotechnology companies. His extensive expertise spans a broad range of therapeutic areas, including neurology, cardiology, infectious disease, hematology, oncology, women’s health, and diagnostic imaging, as well as drug/device combinations. He has contributed to successful NDA and BLA submissions for Cubicin® (Cubist Pharmaceuticals) and Kalbitor® (Dyax Corporation).

Mr. Brazier earned a Bachelor of Science degree from Salem State University and received his PMP certification from the Project Management Institute. He has also served in the United States Air Force and Massachusetts Air National Guard and is a graduate of the USAF Non-Commissioned Officer Leadership School.